NCT02544022 2026-04-07
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
National Institutes of Health Clinical Center (CC)
Recruiting
National Institutes of Health Clinical Center (CC)
AstraZeneca
National Institutes of Health Clinical Center (CC)